The Brain Journal Annual Conference is the largest neuroscience conference for medical professionals, scientists, educators and students in the world. It is a day of interactive learning and networking opportunities centered on the brain, mind, behavior and nervous system. The annual conference provides an opportunity for attendees to learn about the latest research in neuroscience from some of the leading professionals in their field. This one-day event features keynote speakers and more than 20 breakout sessions covering a variety of topics related to neuroscience, ranging from Alzheimer’s disease to depression to Parkinson’s disease. The Brain Journal Annual Conference is a wonderful opportunity for networking with fellow scientists as well as potential employers and future collaborators. The Brain Journal Annual Conference will be held at the Scripps Research Institute in La Jolla, California.
What to Expect at The Brain Journal Annual Conference?
The Brain Journal Annual Conference begins at 8:30 am at the Scripps Research Institute in La Jolla, California. Attendees will hear from keynote speakers and have the opportunity to network with other attendees and presenters in a relaxed setting. This event is a wonderful opportunity to learn more about the most recent neuroscience research and technology breakthroughs. The keynote speakers will include Dr Philip Low, Dr Nancy J. Crider and Dr David Stiles. Dr Low is the Director of the Centre for Human Psychopharmacology at the Swinburne University of Technology in Melbourne, Australia. Dr Crider is a Professor of Psychiatry at the University of California, San Diego. Dr Stiles is the Chief Scientific Officer at Threshold Pharmaceuticals and a Professor in the Department of Neurosciences at the University of California, San Diego.
Key Takeaways from the Brain Research and Technology Panel
The Brain Research and Technology Panel will provide a variety of insights and takeaways for the future of brain research and technology. Some of the topics to be discussed include the effect of climate change on the brain, advances in brain imaging and gene therapy for the treatment of brain disorders. The panel will be moderated by Dr Philip Low.
Depression: A Neuroscientist's View of Hope Through Biological Treatment
Dr Jonathan Lennox will discuss his research on the biology of depression. Depression is a common and debilitating disorder that affects about 15% of the adult population. Many different types of psychotherapy and antidepressant medications are currently available, but the precise causes of depression are not well understood. Dr Lennox and his team are working to discover the biological causes of depression and to develop new treatments that are directly targeted to these biological abnormalities. His research includes studies of how the brain is wired during depression and how it changes as the illness remits. He also studies the effects of stress on the brain. Dr Lennox is an Associate Professor of Neurosciences and Psychiatry at the University of California, San Diego.
Alzheimer’s Disease: From Risk Factors to Prevention and Beyond
Dr Thomas Samaras will discuss current research on Alzheimer’s disease risk factors, diagnosis and treatment. Alzheimer’s disease is the most common form of dementia. It is a neurodegenerative disease that is progressive and fatal. Although it can occur at any age, it is most commonly diagnosed after age 65. Dr Samaras and his team at the Pacific Health Research and Education Institute are working to understand the progression of the disease and to develop new treatments that can stop or reverse Alzheimer’s. Dr Samaras is a Professor of Neurosciences and Psychiatry at the University of California, San Diego.
Schizophrenia: An Update on Genetics, Environment and Brain Changes
Dr John H. Halper and his team will discuss the neurobiology of schizophrenia. Schizophrenia is a complex genetic mental illness that affects 1% of the population. The disease has a substantial social and financial cost worldwide. Dr Halper’s research may lead to improved diagnosis and treatment for schizophrenia. Dr Halper is an Assistant Professor of Neurosciences at the University of California, San Diego.
Parkinson’s Disease: Lessons from Genes and the Environment in Advancement of Treatment
Dr Jennifer Fox will discuss her research on the genetics and environment of Parkinson’s disease. Parkinson’s disease is a common neurodegenerative disease that affects people of all ages. It is estimated that 1% of the population will develop this disease at some point during their lifetime. Dr Fox’s research is focused on discovering the gene mutations that cause Parkinson’s disease. Her team is also investigating how the environment can contribute to the risk of developing the disease. Dr Fox is an Associate Professor of Neurosciences at the University of California, San Diego.
Conclusion
The Brain Journal Annual Conference is a wonderful opportunity for neuroscience professionals and students to network with each other and learn from some of the leading researchers in their field.
What Age is it Best to Get Life Insurance
Hints and Tricks Real Estate Entrepreneurship
The Experimental Biology Yearly Conference
The Biochemistry Global Summit Convention
The American Association for Cancer Research Annual Meeting
International Behavioural Neuroscience Society Yearly Conference